2006
DOI: 10.1016/j.pharmthera.2005.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan

Abstract: This paper reviews the preclinical and clinical evidence regarding the use of the dietary supplement 5-hydroxytryptophan (5-HTP) for the treatment of depression. In the absence of supplementation with exogenous 5-HTP, the amount of endogenous 5-HTP available for serotonin synthesis depends on the availability of tryptophan and on the activity of various enzymes, especially tryptophan hydroxylase, indoleamine 2,3-dioxygenase, and tryptophan 2,3-dioxygenase (TDO). Factors affecting each of these are reviewed. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
158
0
4

Year Published

2008
2008
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 269 publications
(171 citation statements)
references
References 104 publications
3
158
0
4
Order By: Relevance
“…Only later it was established that the efficacy of these drugs is much lower than first thought and probably only slightly better than placebo [1]. Thus, when all studies, either published or unpublished, submitted to the FDA were considered, the number of positive randomized controlled trials was only 51% [45,46]. This lack of effect of serotonergic drugs might be regarded as proof that antidepressants such as SSRIs cannot be regarded as "diseasecentred" drugs, i.e.…”
Section: Gaps and Required Improvements: New Treatmentsmentioning
confidence: 99%
“…Only later it was established that the efficacy of these drugs is much lower than first thought and probably only slightly better than placebo [1]. Thus, when all studies, either published or unpublished, submitted to the FDA were considered, the number of positive randomized controlled trials was only 51% [45,46]. This lack of effect of serotonergic drugs might be regarded as proof that antidepressants such as SSRIs cannot be regarded as "diseasecentred" drugs, i.e.…”
Section: Gaps and Required Improvements: New Treatmentsmentioning
confidence: 99%
“…Inúmeros estudos envolvendo a neurociência nutricional têm procurado dar destaque e pesquisar as formas de alterar a química cerebral com os nutrientes 4,23 . Nesse sentido, acredita-se que exista uma grande relação entre inadequação alimentar, desequilíbrio na neurotransmissão e alterações neurológicas importantes.…”
Section: I S C U S S ã Ounclassified
“…Contudo, nenhuma diferença foi observada sobre o ganho de peso. O efeito do triptofano sobre a ingestão alimentar pode ser uma consequência do aumento da serotonina no cére-bro, devido a uma maior disponibilidade plasmática do seu precursor, o aminoácido triptofano 4,23 . Confirmando essa hipótese, estudos têm mostrado que tratamento com triptofano é capaz de provocar alterações significantes no sistema serotoninérgico 12,26 .…”
Section: I S C U S S ã Ounclassified
“…In the central nervous system, serotonin is used for communication, and it appears to augment the perception of well-being and modulate the intensity of emotional states. Serotonin also has some cognitive functions, including memory and learning [22]. Melatonin is a strong antioxidant, delays the ageing processes, neutralizing free radicals, such as the hydroxyl radical, so melatonin may reduce the damage caused by some types of Parkinson's disease [23,24].…”
Section: Introductionmentioning
confidence: 99%